113 related articles for article (PubMed ID: 20629413)
1. Impact of e-detailing on the number of new prescriptions.
Gönül FF; Carter FJ
Health Care Manag Sci; 2010 Jun; 13(2):101-11. PubMed ID: 20629413
[TBL] [Abstract][Full Text] [Related]
2. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
Datta A; Dave D
Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
[TBL] [Abstract][Full Text] [Related]
3. Influence of pharmaceutical promotion on prescribers in Jordan.
Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of physicians targeted by the pharmaceutical industry to participate in e-detailing.
Alkhateeb FM; Khanfar NM; Doucette WR; Loudon D
Health Mark Q; 2009; 26(2):98-116. PubMed ID: 19408179
[TBL] [Abstract][Full Text] [Related]
5. Physicians' decision process for drug prescription and the impact of pharmaceutical marketing mix instruments.
Campo K; De Staebel O; Gijsbrechts E; van Waterschoot W
Health Mark Q; 2005; 22(4):73-107. PubMed ID: 16597584
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study.
Hincapie A; Schlosser E; Damachi U; Neff E; Llambi L; Groves K; MacKinnon NJ
BMJ Open; 2021 Jan; 11(1):e041098. PubMed ID: 33462098
[TBL] [Abstract][Full Text] [Related]
7. A new debate for Turkish physicians: e-detailing.
Ventura K; Baybars M; Dedeoglu AO
Health Mark Q; 2012; 29(4):362-77. PubMed ID: 23210675
[TBL] [Abstract][Full Text] [Related]
8. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
Ansari B
Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
[TBL] [Abstract][Full Text] [Related]
9. Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Oldani MJ
Med Anthropol Q; 2004 Sep; 18(3):325-56. PubMed ID: 15484967
[TBL] [Abstract][Full Text] [Related]
10. Effect of drug sample removal on prescribing in a family practice clinic.
Hartung DM; Evans D; Haxby DG; Kraemer DF; Andeen G; Fagnan LJ
Ann Fam Med; 2010; 8(5):402-9. PubMed ID: 20843881
[TBL] [Abstract][Full Text] [Related]
11. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
King M; Bearman PS
Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical payments to physicians may increase prescribing for opioids.
Nguyen TD; Bradford WD; Simon KI
Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
[TBL] [Abstract][Full Text] [Related]
13. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
[TBL] [Abstract][Full Text] [Related]
14. E-detailing: information technology applied to pharmaceutical detailing.
Montoya ID
Expert Opin Drug Saf; 2008 Nov; 7(6):635-41. PubMed ID: 18983210
[TBL] [Abstract][Full Text] [Related]
15. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
Strang D; Gagnon M; Molloy W; Bedard M; Darzins P; Etchells E; Davidson W
Ann R Coll Physicians Surg Can; 1996 Dec; 29(8):474-8. PubMed ID: 12380577
[TBL] [Abstract][Full Text] [Related]
16. Influences on physicians' adoption of electronic detailing (e-detailing).
Alkhateeb FM; Doucette WR
Inform Health Soc Care; 2009 Jan; 34(1):39-52. PubMed ID: 19306198
[TBL] [Abstract][Full Text] [Related]
17. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
[TBL] [Abstract][Full Text] [Related]
18. Academic detailing.
Shankar PR; Jha N; Piryani RM; Bajracharya O; Shrestha R; Thapa HS
Kathmandu Univ Med J (KUMJ); 2010; 8(29):126-34. PubMed ID: 21209521
[TBL] [Abstract][Full Text] [Related]
19. Influence of pharmaceutical marketing mix strategies on physicians' prescribing behaviors in public and private hospitals, Dessie, Ethiopia: a mixed study design.
Hailu AD; Workneh BD; Kahissay MH
BMC Public Health; 2021 Jan; 21(1):65. PubMed ID: 33413248
[TBL] [Abstract][Full Text] [Related]
20. The role of marketing in pharmaceutical research and development.
Calfee JE
Pharmacoeconomics; 2002; 20 Suppl 3():77-85. PubMed ID: 12457428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
